Fluorogenic Kinase Sensors Using Quinoline Chelators

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current kinase assays lack sensitivity and brightness, often relying on radioactive materials or background fluorescence interference, which are unsafe and inefficient for measuring kinase activity accurately.

Innovation Solution

Development of kinase sensors comprising a metal chelator with a quinoline group, conjugated with a fluorophore and amino acid, specifically designed to increase fluorescence upon phosphorylation, allowing for real-time, safe, and sensitive measurement of kinase activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional radioactive assays are used to measure kinase activity, then measurement sensitivity can be achieved, but safety hazards and disposal problems arise

Engineering Contradiction:
Improvekinase activity measurement sensitivityVSAvoidradioactive material safety hazards
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The invention changes the detection parameter from radioactive signal to fluorogenic signal. The kinase sensor comprises a fluorophore that remains non-fluorescent until phosphorylated by kinase activity, at which point it becomes highly fluorescent. This parameter change eliminates radioactive hazards while maintaining measurement sensitivity through the bright fluorogenic signal that is red-shifted from background fluorescence.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention substitutes the radioactive detection mechanism with a fluorometric detection mechanism. Instead of using radioactive isotopes that emit detectable radiation, the patent uses a fluorophore that emits fluorescence upon phosphorylation. This substitution replaces the harmful radioactive system with a safe optical detection system that provides equivalent or superior measurement capability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Object-affected harmful factors

If current fluorometric methods are used for kinase detection, then safety is improved compared to radioactivity, but signal brightness and signal-to-noise ratio are insufficient

Engineering Contradiction:
Improvesafety from radioactive materialVSAvoidsignal-to-noise ratio and brightness
Core Design Contradiction:
Object-affected harmful factorsVSMeasurement precision

Solution Approach 1:

The invention changes the fluorophore parameters to achieve red-shifted emission wavelengths that avoid background fluorescence interference from cell lysates, live cells, and drug compounds. By selecting fluorophores with emission wavelengths in the red region of the spectrum, the patent achieves both safety and high signal-to-noise ratio, as this spectral region has minimal biological background interference.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The kinase sensor is designed to be non-fluorescent in its unphosphorylated state, effectively performing a preliminary 'dark' state preparation. This allows any fluorescence signal detected after kinase activity to be attributed specifically to the phosphorylation event, eliminating background noise and achieving high signal-to-noise ratio without requiring complex subtraction procedures.

Inventive Principle:
Principle #10Preliminary action

3Object-affected harmful factors

If sulfonamide substituted quinoline compounds are used as kinase sensors, then safety and sensitivity are achieved, but fluorescence brightness is insufficient

Engineering Contradiction:
Improvesafety from radioactivityVSAvoidfluorescence brightness
Core Design Contradiction:
Object-affected harmful factorsVSIllumination intensity

Solution Approach 1:

The invention creates a composite kinase sensor structure that combines a fluorophore with a quinoline-based metal chelating group. The fluorophore provides bright red-shifted fluorescence, while the quinoline group chelates metal ions (such as Mg2+) that are released upon kinase-mediated phosphorylation. This composite structure enables the sensor to remain non-fluorescent until phosphorylation occurs, at which point metal chelation activates intense fluorescence, thereby achieving both safety and high brightness.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent changes the fluorophore parameters to use compounds with red-shifted absorption and emission spectra, such as coumarins, xanthenes, and cyanines. These fluorophores have higher quantum yields and emit at wavelengths where biological background is minimal, thereby dramatically increasing fluorescence brightness compared to the sulfonamide substituted quinoline compounds while maintaining the safe, non-radioactive detection approach.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The kinase sensors provide a reliable and accurate method for measuring kinase activity with enhanced sensitivity and brightness, reducing interference from background fluorescence and eliminating the need for radioactive materials.

Implementation Method 1

fluorescent kinase assays where the ideal fluorophores used would be bright enough to provide adequate signal to noise

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

the quinoline group chelates magnesium

Methodology Applied
Scientific EffectMetal chelation:

Data Source

PatentUS8124368B2Fluorogenic protein kinase substrates
Publication Date: 2012.02.28 LIFE TECHNOLOGIES CORP
  • US8124368B2 patent drawing
  • US8124368B2 patent drawing
  • US8124368B2 patent drawing

AI summary

The present invention relates to kinase sensors comprising a metal chelator and a fluorophore, where the chelator comprises a quinoline group and where the fluorophore is conjugated to the chelator. The invention also relates to methods of using these kinase sensors as well as kits comprising the kinase sensors.